Correlation Between Aileron Therapeutics and Oncology Pharma

Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Oncology Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Oncology Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aileron Therapeutics and Oncology Pharma, you can compare the effects of market volatilities on Aileron Therapeutics and Oncology Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Oncology Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Oncology Pharma.

Diversification Opportunities for Aileron Therapeutics and Oncology Pharma

0.13

Correlation Coefficient

Aileron Therapeutics  Oncology Pharma

Average diversification

The 3 months correlation between Aileron and Oncology is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Oncology Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncology Pharma and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Oncology Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncology Pharma has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Oncology Pharma go up and down completely randomly.

Pair Corralation between Aileron Therapeutics and Oncology Pharma

Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the Oncology Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Aileron Therapeutics is 56.99 times less risky than Oncology Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The Oncology Pharma is currently generating about 0.36 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Oncology Pharma on September 13, 2024 and sell it today you would earn a total of  0.01  from holding Oncology Pharma or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	92.06%
Values	Daily Returns

Aileron Therapeutics  vs.  Oncology Pharma

Aileron Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aileron Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Oncology Pharma

Risk-Adjusted Performance

27 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Oncology Pharma are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Oncology Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aileron Therapeutics and Oncology Pharma

The main advantage of trading using opposite Aileron Therapeutics and Oncology Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Oncology Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Pharma will offset losses from the drop in Oncology Pharma's long position.

The idea behind Aileron Therapeutics and Oncology Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.